Medicine & Life Sciences
Cell Transplantation
100%
Allogeneic Cells
49%
Precursor Cell Lymphoblastic Leukemia-Lymphoma
44%
Survival
42%
Transplants
39%
Lymphoma
38%
Hodgkin Disease
38%
Transplantation
35%
Recurrence
32%
Natural Killer Cells
32%
Mantle-Cell Lymphoma
30%
Chimeric Antigen Receptors
30%
Lymphoma, Large B-Cell, Diffuse
30%
Progression-Free Survival
29%
Graft vs Host Disease
26%
Hematopoietic Stem Cell Transplantation
25%
Non-Hodgkin's Lymphoma
25%
Stem Cell Transplantation
25%
Cell- and Tissue-Based Therapy
24%
Fetal Blood
24%
Tissue Donors
24%
Confidence Intervals
23%
Bone Marrow
23%
B-Cell Lymphoma
23%
Homologous Transplantation
21%
Leukemia
21%
tisagenlecleucel
20%
Rituximab
19%
T-Lymphocytes
19%
Therapeutics
18%
Cyclophosphamide
17%
Unrelated Donors
17%
Hematologic Neoplasms
17%
Mortality
16%
Brentuximab Vedotin
13%
Acute Myeloid Leukemia
13%
Siblings
13%
fludarabine
13%
Drug Therapy
13%
Autologous Transplantation
12%
B-Lymphocytes
12%
Neoplasms
11%
Interleukin-15
11%
Allografts
10%
Follicular Lymphoma
10%
Incidence
9%
KIR Receptors
9%
CD19 Antigens
9%
Cytokine Release Syndrome
9%
Whole-Body Irradiation
8%